Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days

New feature: Introducing the Finviz Matrix

Changes in company's own shares

By Alvotech | December 29, 2025, 2:40 PM

Attached is a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding changes in company's own shares.

Attachment

Alvotech Own Shares Notification 29 Dec 2025

Mentioned In This Article

Latest News

Aug-31	Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio to Subcutaneous Presentations ALVO GlobeNewswire
Aug-27	Alvotech to present at upcoming investor conferences in September ALVO GlobeNewswire
Aug-24	BofA starts bullish Alvotech coverage on biosimilar launch cycle ALVO +18.51% Investing.com
Aug-21	Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets ALVO GlobeNewswire
Aug-20	Alvotech Q2 2026 Earnings Call Summary ALVO +7.02% Moby
Aug-19	Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update ALVO GlobeNewswire
Aug-19	Earnings To Watch: Alvotech (ALVO) Q2 2026 -- GF Value Sees 461% Upside ALVO GuruFocus.com
Aug-18	Earnings To Watch: Alvotech (ALVO) Q2 2026 -- GF Value Sees 471% Upside ALVO GuruFocus.com
Aug-10	Alvotech to Report Financial Results for H1 2026 ALVO GlobeNewswire
Jul-29	Alvotech announces successful closure of FDA inspection of manufacturing facility ALVO +13.87% GlobeNewswire
Jul-03	Transactions of Managers and Closely Associated Persons ALVO GlobeNewswire
Jul-01	Alvotech further strengthens liquidity by securing term loan facility of $75 million ALVO GlobeNewswire
Jun-22	Transactions of Managers and Closely Associated Persons ALVO -6.89% GlobeNewswire
Jun-18	Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement ALVO GlobeNewswire
Jun-18	Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares ALVO GlobeNewswire

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)